Therapeutic agents for steroid-refractory immune checkpoint inhibitor-related myocarditis: a narrative review
Cardiovascular Diagnosis and Therapy · 2024-08 · 14 (4) · 679-697
DOI: 10.21037/cdt-24-114 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cardiovascular Diagnosis and Therapy, 2024-08. Verfasst von Yang Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Traditional Chinese Medicine, Heilongjiang University of Chinese Medicine, Harbin, China. Die Arbeit wurde bisher 12-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Traditional Chinese Medicine, Heilongjiang University of Chinese Medicine, Harbin, China.
- Jiangsu Hengrui Pharmaceuticals Co., Ltd., Lianyungang, China.
- Department of Manufacturing Laboratory, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China.
ORCID-Profile: Yang Wang
Zitieren
APA
Wang, Y., Li, S., Shi, H., Guan, X., Wei, Q., & Chen, D. (2024). Therapeutic agents for steroid-refractory immune checkpoint inhibitor-related myocarditis: a narrative review. Cardiovascular Diagnosis and Therapy, 14(4), 679-697. https://doi.org/10.21037/cdt-24-114
Vancouver
Wang Y, Li S, Shi H, Guan X, Wei Q, Chen D. Therapeutic agents for steroid-refractory immune checkpoint inhibitor-related myocarditis: a narrative review. Cardiovascular Diagnosis and Therapy. 2024;14(4):679-697. doi:10.21037/cdt-24-114
BibTeX
@article{Wang2024,
author = {Wang, Yang and Li, Shouchao and Shi, He and Guan, Xue and Wei, Qiang and Chen, Dazhong},
title = {Therapeutic agents for steroid-refractory immune checkpoint inhibitor-related myocarditis: a narrative review},
journal = {Cardiovascular Diagnosis and Therapy},
year = {2024},
volume = {14},
number = {4},
pages = {679--697},
doi = {10.21037/cdt-24-114}
}
EUVIMED